68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor.
Saved in:
| Title: | 68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor. |
|---|---|
| Authors: | Shell J; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Keutgen XM; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Millo C; Positron Emission Department, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.; Positron Emission Department, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA., Nilubol N; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Patel D; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Sadowski S; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Boufraqech M; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Yang L; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Merkel R; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Atallah C; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Herscovitch P; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Kebebew E; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. |
| Source: | International journal of endocrine oncology [Int J Endocr Oncol] 2018 Feb 02; Vol. 5 (1), pp. IJE04. Date of Electronic Publication: 2018 Feb 02 (Print Publication: 2018). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Future Medicine part of fsg Country of Publication: England NLM ID: 101648548 Publication Model: eCollection Cited Medium: Print ISSN: 2045-0869 (Print) Linking ISSN: 20450869 NLM ISO Abbreviation: Int J Endocr Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30112163 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shell+J%22">Shell J</searchLink>; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Keutgen+XM%22">Keutgen XM</searchLink>; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Millo+C%22">Millo C</searchLink>; Positron Emission Department, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.; Positron Emission Department, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Nilubol+N%22">Nilubol N</searchLink>; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Patel+D%22">Patel D</searchLink>; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Sadowski+S%22">Sadowski S</searchLink>; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Boufraqech+M%22">Boufraqech M</searchLink>; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Yang+L%22">Yang L</searchLink>; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Merkel+R%22">Merkel R</searchLink>; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Atallah+C%22">Atallah C</searchLink>; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Herscovitch+P%22">Herscovitch P</searchLink>; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Kebebew+E%22">Kebebew E</searchLink>; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101648548%22">International journal of endocrine oncology</searchLink> [Int J Endocr Oncol] 2018 Feb 02; Vol. 5 (1), pp. IJE04. <i>Date of Electronic Publication: </i>2018 Feb 02 (<i>Print Publication: </i>2018). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Future+Medicine+part+of+fsg%22">Future Medicine part of fsg </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101648548 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2045-0869 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220450869%22">20450869 </searchLink><i>NLM ISO Abbreviation: </i>Int J Endocr Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30112163 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2217/ije-2017-0005 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: IJE04 Titles: – TitleFull: 68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shell J – PersonEntity: Name: NameFull: Keutgen XM – PersonEntity: Name: NameFull: Millo C – PersonEntity: Name: NameFull: Nilubol N – PersonEntity: Name: NameFull: Patel D – PersonEntity: Name: NameFull: Sadowski S – PersonEntity: Name: NameFull: Boufraqech M – PersonEntity: Name: NameFull: Yang L – PersonEntity: Name: NameFull: Merkel R – PersonEntity: Name: NameFull: Atallah C – PersonEntity: Name: NameFull: Herscovitch P – PersonEntity: Name: NameFull: Kebebew E IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 02 Text: 2018 Feb 02 Type: published Y: 2018 Identifiers: – Type: issn-print Value: 2045-0869 Numbering: – Type: volume Value: 5 – Type: issue Value: 1 Titles: – TitleFull: International journal of endocrine oncology Type: main |
| ResultId | 1 |